The SNPs of the IL-6 gene have been reported to influence the histologic progression and clinical outcomes of HCV patients [26–28] but there is a great disparity in the correlation between IL-6 gene polymorphisms and hepatitis-related HCC according to the literature [29, 30]. The gene discussed is IL6; the disease is hepatocellular carcinoma.